Considering the urgency of the ongoing COVID-19 pandemic, detection of various new mutant strains and future potential re-emergence of novel coronaviruses, repurposing of approved drugs such as Ivermectin could be worthy of attention. This evidence-based review article aims to discuss the mechanism of action of ivermectin against SARS-CoV-2 and summarizing the available literature over the years. A schematic of the key cellular and biomolecular interactions between Ivermectin, host cell, and SARS-CoV-2 in COVID-19 pathogenesis and prevention of complications have been proposed.
Glad to announce that our Evidence-based clinical review article- Mechanisms of action of Ivermectin against SARS-CoV-2 has been published in Springer Nature
Click on this link to read the article
https://www.nature.com/articles/s41429-021-00430-5
We hope this manuscript would improve the knowledge around the so debated “I” drug.
On behalf of Associazione Naso Sano
Dr. Asiya Kamber Zaidi & Dr. Puya Dehgani Mobaraki
0 commenti su “Meccanismi di azione dell’ Ivermectina – An evidence-based clinical review article published on the Journal of Antibiotics 15 June 2021”